摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(furan-2-ylmethylidene)chromen-4-one | 911293-88-4

中文名称
——
中文别名
——
英文名称
3-(furan-2-ylmethylidene)chromen-4-one
英文别名
——
3-(furan-2-ylmethylidene)chromen-4-one化学式
CAS
911293-88-4
化学式
C14H10O3
mdl
——
分子量
226.232
InChiKey
SVYMCFOGHUGTIA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.94
  • 重原子数:
    17.0
  • 可旋转键数:
    1.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    39.44
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(furan-2-ylmethylidene)chromen-4-one 在 bis(1,5-cyclooctadiene)diiridium(I) dichloride 、 氢气 、 C46H66FeNO2P 、 sodium hydroxide 作用下, 以 正己烷 为溶剂, 20.0 ℃ 、5.0 MPa 条件下, 反应 12.0h, 以99%的产率得到(3R,4R)-3-(furan-2-ylmethyl)chroman-4-ol
    参考文献:
    名称:
    Ir/f-Ampha配合物催化烯酮的不对称顺序氢化:获得具有两个连续手性中心的手性醇的一般途径
    摘要:
    通过使用铱/f-Ampha 配合物作为催化剂,开发了一种通用且高效的 α,β-不饱和酮的不对称顺序氢化方法,以高收率提供具有两个连续立体中心的相应手性醇,并具有优异的非对映和对映选择性(高达 99% 的产率,>20 : 1 dr 和 >99% ee)。对照实验表明,烯酮的 C C 和 C O 键依次氢化,最终的立体选择性由酮的动态动力学拆分决定。此外,DFT 计算表明,外球途径参与了 C C 和 C的减少。O 烯酮键。该方法的合成效用通过克级反应和极低催化剂负载量 (S/C = 20 000) 和获得抗哮喘药物 CP-199,330 的关键手性中间体的简明合成路线得到证明。
    DOI:
    10.1039/d1sc05963g
  • 作为产物:
    描述:
    糠醛2,3-二氢苯并吡喃-4-酮 在 sodium hydroxide 作用下, 以 乙醇 为溶剂, 生成 3-(furan-2-ylmethylidene)chromen-4-one
    参考文献:
    名称:
    Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship
    摘要:
    Designed and synthesized were a series of 5H-chromeno[4,3-b]pyridines with substitution at 2- and 4-positions with various 5- or 6-membered heteroaromatics as antitumor agents. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Structure activity relationship study showed that 2-furyl or 2-thienyl at 2- or 4-position of central pyridine is crucial in displaying topo I or II inhibitory activity and cytotoxicity. (C) 2011 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2011.04.029
点击查看最新优质反应信息

文献信息

  • Base-Catalyzed Traceless Silylation and Deoxygenative Cyclization of Chalcones to Cyclopropanes
    作者:Manas Kumar Sahu、Shubham Jaiswal、Sandip Pattanaik、Chidambaram Gunanathan
    DOI:10.1021/acs.joc.2c00374
    日期:2022.5.20
    synthetic methods from readily available compounds to complex products is of utmost interest in modern synthesis. Catalytic synthesis of cyclopropanes is important for diverse chemical applications. We present a method for the transformation of readily accessible α,β-unsaturated ketones (chalcones) to cyclopropanes. A simple base, KOH, catalyzed the selective reduction of the enone carbonyl functionality
    开发从容易获得的化合物到复杂产品的简单合成方法是现代合成的最大兴趣所在。环丙烷的催化合成对于各种化学应用很重要。我们提出了一种将容易获得的 α,β-不饱和酮(查耳酮)转化为环丙烷的方法。简单的碱 KOH 催化烯酮羰基官能团的选择性还原、脱氢甲硅烷基化和查耳酮的脱氧环化以提供环丙烷产物。具有扩展共轭和 4-色满酮底物的查耳酮也提供了相应的环丙烷。
  • Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship
    作者:Uttam Thapa、Pritam Thapa、Radha Karki、Minho Yun、Jae Hun Choi、Yurngdong Jahng、Eunyoung Lee、Kyung-Hwa Jeon、Younghwa Na、Eun-Mi Ha、Won-Jea Cho、Youngjoo Kwon、Eung-Seok Lee
    DOI:10.1016/j.ejmech.2011.04.029
    日期:2011.8
    Designed and synthesized were a series of 5H-chromeno[4,3-b]pyridines with substitution at 2- and 4-positions with various 5- or 6-membered heteroaromatics as antitumor agents. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Structure activity relationship study showed that 2-furyl or 2-thienyl at 2- or 4-position of central pyridine is crucial in displaying topo I or II inhibitory activity and cytotoxicity. (C) 2011 Elsevier Masson SAS. All rights reserved.
  • 2,4-Diaryl-5H-chromeno [4,3-b]pyridines: Synthesis, Topoisomerase I and II Inhibitory Activity, and Cytotoxicity
    作者:Pritam Thapa、Eung-Seok Lee
    DOI:10.5012/bkcs.2012.33.9.3103
    日期:2012.9.20
  • A Series of Novel Terpyridine-Skeleton Molecule Derivants Inhibit Tumor Growth and Metastasis by Targeting Topoisomerases
    作者:Han-Byeol Kwon、Chanmi Park、Kyung-Hwa Jeon、Eunyoung Lee、So-Eun Park、Kyu-Yeon Jun、Tara Man Kadayat、Pritam Thapa、Radha Karki、Younghwa Na、Mi Sun Park、Seung Bae Rho、Eung-Seok Lee、Youngjoo Kwon
    DOI:10.1021/jm501023q
    日期:2015.2.12
    A series of novel terpyridine-skeleton molecules containing conformational rigidity, 14 containing benzo[4,5]furo[3,2-b]pyridine core and 15 comprising chromeno[4,3-b]pyridine core, were synthesized, and their biological activities were evaluated. 3-(4-Phenylbenzo[4,5]furo[3,2-b]pyridin-2-yl)phenol (8) was determined to be a nonintercalative topo I and II dual catalytic inhibitor and 3-(4-phenylchromeno[4,3-b]pyridine-2-yl)phenol (22) was determined to be a nonintercalative topo II alpha specific catalytic inhibitor by various assays. These two catalytic inhibitors induced apoptosis in addition to G1 arrest in T47D human breast cancer cells with much less DNA toxicity than etoposide. Compounds 8 and 22 significantly inhibited tumor growth in HCT15 subcutaneously implanted xenografted mice. The modification of compounds 8 and 22 with the introduction of a methoxy instead of a hydroxy group enhanced endogenous topo inhibitory activity, metabolic stability in diverse types of liver microsomes and improved pharmacokinetic parameters in rat plasma such as augmentation of bioavailability (41.3% and 33.2% for 2-(3-methoxyphenyl)-4-phenylbenzofuro[3,2-b]pyridine (8-M) and 3-(4-phenylchromeno[4,3-b]pyridine-2-yl)methoxybenzene (22-M), respectively).
  • Ir/f-Ampha complex catalyzed asymmetric sequential hydrogenation of enones: a general access to chiral alcohols with two contiguous chiral centers
    作者:Wendian Li、Tilong Yang、Nan Song、Ruihao Li、Jiao Long、Lin He、Xumu Zhang、Hui Lv
    DOI:10.1039/d1sc05963g
    日期:——
    A general and highly efficient method for asymmetric sequential hydrogenation of α,β-unsaturated ketones has been developed by using an iridium/f-Ampha complex as the catalyst, furnishing corresponding chiral alcohols with two contiguous stereocenters in high yields with excellent diastereo- and enantioselectivities (up to 99% yield, >20 : 1 dr and >99% ee). Control experiments indicated that the CC
    通过使用铱/f-Ampha 配合物作为催化剂,开发了一种通用且高效的 α,β-不饱和酮的不对称顺序氢化方法,以高收率提供具有两个连续立体中心的相应手性醇,并具有优异的非对映和对映选择性(高达 99% 的产率,>20 : 1 dr 和 >99% ee)。对照实验表明,烯酮的 C C 和 C O 键依次氢化,最终的立体选择性由酮的动态动力学拆分决定。此外,DFT 计算表明,外球途径参与了 C C 和 C的减少。O 烯酮键。该方法的合成效用通过克级反应和极低催化剂负载量 (S/C = 20 000) 和获得抗哮喘药物 CP-199,330 的关键手性中间体的简明合成路线得到证明。
查看更多